CTEC has been the subject of several other reports. Numis Securities restated a hold rating on shares of ConvaTec Group in a report on Thursday, August 2nd. Deutsche Bank reiterated a sell rating on shares of ConvaTec Group in a report on Wednesday, July 4th. Finally, Royal Bank of Canada reiterated an outperform rating and set a GBX 240 ($3.14) target price on shares of ConvaTec Group in a report on Wednesday, August 8th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the company. The stock presently has a consensus rating of Hold and a consensus target price of GBX 222 ($2.90).
Shares of CTEC opened at GBX 224.20 ($2.93) on Wednesday. ConvaTec Group has a one year low of GBX 181.40 ($2.37) and a one year high of GBX 349.10 ($4.56).
The company also recently declared a dividend, which was paid on Friday, October 12th. Investors of record on Thursday, September 6th were given a dividend of GBX 1.31 ($0.02) per share. The ex-dividend date was Thursday, September 6th. This represents a dividend yield of 0.58%. This is an increase from ConvaTec Group’s previous dividend of $0.04.
In other news, insider Sten Scheibye purchased 22,500 shares of ConvaTec Group stock in a transaction that occurred on Thursday, August 2nd. The stock was bought at an average price of GBX 223 ($2.91) per share, with a total value of £50,175 ($65,562.52).
About ConvaTec Group
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes.
Featured Story: Diversification Important in Investing
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.